John Piletz

Summary

Affiliation: Loyola University Medical Center
Country: USA

Publications

  1. pmc Putative agmatinase inhibitor for hypoxic-ischemic new born brain damage
    John E Piletz
    Department of Psychiatry, Stritch School of Medicine, Loyola University Chicago, Loyola University Medical Center, 2160 South First Ave, Maywood, IL 60153, USA
    Neurotox Res 24:176-90. 2013
  2. pmc Database of genetic studies of bipolar disorder
    John E Piletz
    Department of Psychiatry, Loyola University of Chicago, Stritch School of Medicine, Maywood, Illinois 60153, USA
    Psychiatr Genet 21:57-68. 2011

Detail Information

Publications2

  1. pmc Putative agmatinase inhibitor for hypoxic-ischemic new born brain damage
    John E Piletz
    Department of Psychiatry, Stritch School of Medicine, Loyola University Chicago, Loyola University Medical Center, 2160 South First Ave, Maywood, IL 60153, USA
    Neurotox Res 24:176-90. 2013
    ..Piperazine-1-carboxamidine therefore appears to be a neuroprotective agent of a new category, agmatinase inhibitor. ..
  2. pmc Database of genetic studies of bipolar disorder
    John E Piletz
    Department of Psychiatry, Loyola University of Chicago, Stritch School of Medicine, Maywood, Illinois 60153, USA
    Psychiatr Genet 21:57-68. 2011
    ..It can serve as the basis for a mega-analysis of candidate genes. Herein, we discuss the most robust and best replicated gene findings to date in a contextual manner...

Research Grants9

  1. AGMATINASE INHIBITORS FOR HYPOXIC-ISCHEMIC NEW BORN BRAIN DAMAGE
    John Piletz; Fiscal Year: 2007
    ..Specific Aim-4 will test which of the compounds is most neuroprotective in rat pups exposed to hypoxia-ischemia. The overall goal of these studies is to develop a treatment for perinatal brain damage in human infants. ..
  2. IMIDAZOLINE RECEPTORS IN DEPRESSION--BASIC STUDIES
    John Piletz; Fiscal Year: 1999
    ..The findings from the clinical grant will best be understood within the context of these studies in the basic grant, and vice versa. ..
  3. TRANSFER OF GRANT - REGULATION OF LIMDAZOLINE SITES
    John Piletz; Fiscal Year: 1993
    ..These studies will answer fundamental questions about the platelet I1 site, its regulation in health and disease and its possible utility as a marker in depressive illness and PMS...
  4. IMIDAZOLINE RECEPTORS IN DEPRESSION--BASIC STUDIES
    John Piletz; Fiscal Year: 2000
    ..The findings from the clinical grant will best be understood within the context of these studies in the basic grant, and vice versa. ..
  5. IMIDAZOLINE RECEPTORS IN DEPRESSION--BASIC STUDIES
    John Piletz; Fiscal Year: 2001
    ..The findings from the clinical grant will best be understood within the context of these studies in the basic grant, and vice versa. ..
  6. AGMATINASE INHIBITORS FOR HYPOXIC-ISCHEMIC NEW BORN BRAIN DAMAGE
    John Piletz; Fiscal Year: 2006
    ..Specific Aim-4 will test which of the compounds is most neuroprotective in rat pups exposed to hypoxia-ischemia. The overall goal of these studies is to develop a treatment for perinatal brain damage in human infants. ..